Lecture Details - Overview
Harnessing Signal Transduction to Optimize Outcomes in Kidney Cancer
Release Date: October 21, 2008|
Expiration Date: October 21, 2009
Sep 26, 2008, Chicago, IL
Lecture Overview
The Harnessing Signal Transduction to Optimize Outcomes in Kidney Cancer activity will provide oncologists with a clinically relevant overview of the current understanding of tumor and microenvironment cell biology, with applications to the treatment of kidney cancer. This information will be linked to applications in the clinical management of these patients. This educational activity is directed primarily toward medical oncologists interested in the treatment of cancer. Physician assistants, nurses, fellows, pharmacists, and other health care professionals who are interested in the treatment of cancer are also invited to participate.Upon completion of this educational activity, you should be able to:
- Evaluate the rationale for targeting the tumor microenvironment and signal transduction in cancer therapy
- Describe the roles of angiogenesis/vasculogenesis and mTOR signaling in the pathophysiology of renal cell carcinoma
- Describe the clinical efficacy and safety of antiangiogenic agents and mTOR inhibitors in advanced renal cell carcinoma
- Read the following information before beginning the educational activity.
- Complete the pre-test.
- View and study all Flash video presentations.
- Complete the CME test.
- Answer the evaluation questions.
- CME credit will be granted for online participation only.
Instructions for Participation
You will be asked to login
or create an account.